Vaccine and Treatment Evaluation Unit: Pertussis Vaccine Development

疫苗和治疗评估单位：百日咳疫苗开发

• 批准号: 9571899
• 负责人: Kathryn Margaret Edwards
• 金额: $ 33.38万
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-04-07 至 2019-12-01
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9571899
• 关键词: Communicable Diseases; Conduct Clinical Trials; Contracts; Development; Evaluation; Individual; Pertussis Vaccine; Population; Resources; Vaccines; combat; design; named group; programs; vaccine candidate; vaccine development

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该计划由学术中心和组织内的个人合同组成，为临床试验的设计和进行提供现成的资源，以评估有前途的产品来对抗传染病。一般而言，产品将在正常健康人群中进行评价;然而，也可用于特殊人群。